Johnc Bell News Today

Transgene anticipates significant progress from immunotherapy pipeline in 2024 and extends financial visibility until Q4 2025   ­        Lead program TG4050 to deliver data in 2024. ­        Advancements in other clinical pr...

2023 Full-year results and business update Lead program TG4050 to deliver data in 2024. Advancements in other clinical programs and Research and Innovation activity to...

The city was home to an extensive streetcar system that shaped neighborhoods before it was replaced by buses and automobiles.

Cytonus Secures Series A Financing to Advance Pipeline of Novel Cargocyte(TM)-Based ...

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

­ Promising data from ongoing clinical trials of neoantigen cancer vaccine TG4050 and HPV-positive cancer therapeutic vaccine TG4001 presented at key congresses in H1 2023­ Immunogenicity clinical data from ongoing trials confirm mechanism of action of Transgene’s therapeutic vaccines TG4050 and TG4001­ Transgene pl...

Federal American Vernacular Portraits, 1790s to 1840s.

Transgene provides business update and Q1 2023 financial position Dr. Alessandro Riva, MD, appointed as the Company’s Chairman and CEO to accelerate the development of Transgene’s innovative immunotherapy portfolio New clinical data to be communicated in Q2 2023 on TG4001, TG4050...

Positive data on key clinical candidates delivered in 2022 Promising outlook for 2023 as industry interest in therapeutic cancer vaccines and oncolytic viruses gains significant momentum TG4050:New

While many people were sleeping overnight Tuesday, Pennsylvania’s political landscape changed in some significant — and historic — ways. Here are some of the key takeaways from this year’s crucial midterm election: Dems to hold both U.S. Senate seats Democrat John Fetterman declared victory in his U.S. Senate race against